Glycoengineering artificial receptors for microglia to phagocytose Aβ aggregates-Reference-Cited by-同舟云学术

Glycoengineering artificial receptors for microglia to phagocytose Aβ aggregates

Published:2021 Issue:13 Volume:12 Page:4963-4969
ISSN:2041-6520
Container-title:Chemical Science
language:en
Short-container-title:Chem. Sci.

Author:

Yu Dongqin¹²³⁴⁵,Liu Chun¹²³⁴⁵,Zhang Haochen¹²³⁴⁵,Ren Jinsong¹²³⁴⁵^ORCID,Qu Xiaogang¹²³⁴⁵^ORCID

Affiliation:

1. Laboratory of Chemical Biology

2. State Key Laboratory of Rare Earth Resource Utilization

3. Changchun Institute of Applied Chemistry

4. Chinese Academy of Sciences

5. Changchun

Abstract

A combination of metabolic glycoengineering and self-triggered click chemistry is utilized to engineer a microglial membrane with ThS as artificial Aβ receptors to promote microglia to phagocytose Aβ aggregates.

Funder

Chinese Academy of Sciences

National Natural Science Foundation of China

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2021/SC/D0SC07067J

Reference42 articles.

1. The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics

2. Implications of peptide assemblies in amyloid diseases

3. The activities of amyloids from a structural perspective

4. Microglia in neurodegeneration

5. Mechanisms of Aβ Clearance and Degradation by Glial Cells

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metal-organic frameworks for the diagnosis and treatment of Alzheimer’s disease: Current status and perspectives;Coordination Chemistry Reviews;2024-11

2. Application and Development of Cell Membrane Functionalized Biomimetic Nanoparticles in the Treatment of Acute Ischemic Stroke;International Journal of Molecular Sciences;2024-08-05

3. Microenvironment modulating nanogels by Shiitake-derived lentinan and a reactive oxygen species scavenging conjugated polymer for the treatment of Alzheimer’s disease;Nano Today;2024-04

4. Microcurrent therapy as the nonpharmacological new protocol against Alzheimer’s disease;Frontiers in Aging Neuroscience;2024-01-18

5. Biomarker-activated multifunctional lysosome-targeting chimeras mediated selective degradation of extracellular amyloid fibrils;Chem;2023-07